A comprehensive review and meta-analysis revealed that MALAT1 overexpression is linked to poor outcomes in nonsmall cell lung carcinoma (NSCLC), suggesting its potential as a prognostic marker for NSCLC [8]. The gene discussed is MALAT1; the disease is non-small cell lung carcinoma.